jcny development group inc.

106-09 northern blvd.
corona, new york 11368

NYS Entity Status
ACTIVE

NYS Filing Date
JUNE 11, 2014

NYS DOS ID#
4590958

County
QUEENS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - JCNY DEVELOPMENT GROUP INC.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • The Look: New York City Parks in the Summer: Romance, Games and a Performance for a Dying Tree
    By DANIEL ARNOLD, JOANNA NIKAS and EVE LYONS - Saturday Sep 2, 2017

    Daniel Arnold spent the last two months photographing parks in all five boroughs. The experience showed him “a very different pulse of the city.”

    Source: NYT > Home Page
  • Art Review: From China’s Artist-Activist, a Citywide Great Wall
    By JASON FARAGO - Thursday Oct 12, 2017

    Ai Weiwei has endured frequent gripes that his activism has got the better of his art. That gripe is unfounded.

    Source: NYT > Home Page
  • IAB Tech Lab Launches Blockchain Working Group
    Monday Sep 18, 2017

    GroupM, Kochava, MetaX, and Nyiax have become member companies in an IAB Tech Lab working group that launched Monday focused on blockchain and explore ways to use it in digital technology. ShailleySingh leads the group. The working group will initially design ways to educate the industry, set priorities for business use cases and develop standards and best practices. 

    Source: Media Post: Search Marketing Daily
  • Solar Developers and Panel Makers Clash Over Tariff Request
    By DIANE CARDWELL - Tuesday Aug 15, 2017

    Troubled domestic manufacturers say cheap Chinese products have undercut their own, but industry groups are urging a trade panel to reject sanctions.

    Source: NYT > Home Page
  • Aimmune in Brisbane teams with Regeneron to find peanut allergy cure
    By Caroline Chen - Tuesday Oct 17, 2017

    Aimmune Therapeutics Inc. is teaming with Regeneron Pharmaceuticals Inc. in hopes of developing a cure for peanut allergies. Aimmune, based in Brisbane, specializes in food allergy treatments and has been developing a desensitizing therapy, AR101, to protect peanut allergy sufferers against reactions from accidental exposures. By combining AR101 with Regeneron’s inflammation-inhibiting drug Dupixent, the companies are seeking to increase protection enough so patients stop reacting to peanuts even after treatment ends. “What we’re learning is that the immune system does seem to be plastic, and with the right group, you can turn the disease back,” Aimmune’s chief executive officer, Stephen Dilly, said.

    Source: SFGATE.com: Business and Technology News
  • Corona is the New King of Beers
    Thursday Oct 5, 2017

    Constellation Brands, the U.S. distributor of Corona and Modelo, reported a 13% jump in beer sales in the summer months

    Source: The Wall Street Journal: U.S. Business